It is a chemicals and materials limited liability partnership based in Pardi, Gujarat, India, established in 2016.
2016 | Pardi, Gujarat, India | ActiveFaryl Pharmaceuticals Llp, a active limited liability partnership, was established on 29 June 2016 in Pardi, Gujarat, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds LLPIN: AAG-8017. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.
Its leadership includes Chirag Hasmukhlal Doshi (Designated Partner), Gaurav Doshi (Designated Partner), Parag Sureshchandra Doshi (Designated Partner). Past directors included Gaurav Doshi, Sejal Paragkumar Doshi, Gautambhai Jayantilal Doshi. It holds ₹1.77 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at A2-6106, 4Th Phase, G.I.D.C., Vapi, Pardi, Gujarat, 396195.
AAG-8017
29 June 2016
₹0.10 M
Roc Ahmedabad
Active
Explore comprehensive insights into Faryl Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chirag Hasmukhlal Doshi | Designated Partner | 29 Jun 2016 | Current |
| Gaurav Doshi | Designated Partner | 24 Nov 2017 | Current |
| Parag Sureshchandra Doshi | Designated Partner | 29 Jun 2016 | Current |
| Sejal Paragkumar Doshi | Designated Partner | 12 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Partner | 23 Nov 2017 | Past |
| Pramod Abcsdd | Partner | 12 Feb 2024 | Past |
| Pramod Abcsdd | Partner | - | Past |
| Pramod Abcsdd | Partner | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Faryl Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Faryl Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹17,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2018 | Axis Bank Limited | ₹1.77 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Faryl Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Faryl Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Faryl Pharmaceuticals Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Faryl Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.
Progress on Faryl Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
Progress on Sejal Paragkumar Doshi was appointed as a Designated Partner was appointed as a Designated Partner on 12 Feb 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 17.70 M with Charge ID 100218004 was registered on 01 Nov 2018. was completed.
Gaurav Doshi was appointed as a Designated Partner was appointed as a Designated Partner on 24 Nov 2017 & has been associated with this company since 8 years 5 days . was recorded as a recent event.
Chirag Hasmukhlal Doshi was appointed as a Designated Partner was appointed as a Designated Partner on 29 Jun 2016 & has been associated with this company since 9 years 5 months . was recorded as a recent event.
The LLPIN of Faryl Pharmaceuticals Llp is AAG-8017.
Faryl Pharmaceuticals Llp is headquartered at A2-6106, 4Th Phase, G.I.D.C., Vapi, Pardi, Gujarat, 396195.
Faryl Pharmaceuticals Llp was incorporated on 29 June 2016.
The current directors of Faryl Pharmaceuticals Llp are
The primary industry of Faryl Pharmaceuticals Llp is Chemicals And Materials.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX